Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis (Q34408679)

2 August 2017

0 references

1 reference

title

Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

6

1 reference

2 August 2017

2

Giovanni Corona

1 reference

2 August 2017

10

Mario Maggi

1 reference

2 August 2017

3

Linda Vignozzi

1 reference

2 August 2017

1

Mauro Gacci

1 reference

2 August 2017

5

Sergio Serni

1 reference

2 August 2017

7

Andrea Tubaro

1 reference

2 August 2017

8

Matthias Oelke

1 reference

2 August 2017

Matteo Salvi

4

1 reference

PubMed ID

24602293

2 August 2017

Marco Carini

series ordinal

9

1 reference

2 August 2017

16 August 2014

1 reference

2 August 2017

1 reference

2 August 2017

115

1 reference

2 August 2017

1

1 reference

2 August 2017

24-31

1 reference

2 August 2017

The metabolic syndrome

1 reference

Testosterone, cardiovascular disease and the metabolic syndrome

21 January 2018

1 reference

Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes?

21 January 2018

1 reference

Type 2 diabetes mellitus and testosterone: a meta-analysis study.

21 January 2018

1 reference

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

21 January 2018

1 reference

Seminal, ultrasound and psychobiological parameters correlate with metabolic syndrome in male members of infertile couples

21 January 2018

1 reference

Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston area community health survey

21 January 2018

1 reference

The correlation between metabolic syndrome and prostatic diseases

21 January 2018

1 reference

Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.

21 January 2018

1 reference

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

21 January 2018

1 reference

Lower urinary tract symptoms, obesity and the metabolic syndrome

21 January 2018

1 reference

Self-assessed health, sadness and happiness in relation to the total burden of symptoms from the lower urinary tract.

21 January 2018

1 reference

Lower urinary tract symptoms increase the risk of falls in older men

21 January 2018

1 reference

Metabolic syndrome and lower urinary tract symptoms: the role of inflammation.

21 January 2018

1 reference

Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit

21 January 2018

1 reference

Hypertension, diabetes mellitus, and blood groups in benign prostatic hypertrophy.

21 January 2018

1 reference

Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia

21 January 2018

1 reference

Central obesity as a risk factor for prostatic hyperplasia.

21 January 2018

1 reference

Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia.

21 January 2018

1 reference

The association between metabolic syndrome and prostate-specific antigen levels

21 January 2018

1 reference

Relationship between serum prostate-specific antigen levels and components of metabolic syndrome in healthy men.

21 January 2018

1 reference

The association of metabolic syndrome and its components with serum prostate-specific antigen levels in a Korean-screened population

21 January 2018

1 reference

Relationships between Prostate-Specific Antigen, Prostate Volume, and Components of Metabolic Syndrome in Healthy Korean Men.

21 January 2018

1 reference

Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems

21 January 2018

1 reference

The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.

21 January 2018

1 reference

Relationship between lower urinary tract symptoms and metabolic syndrome in a community-based elderly population

21 January 2018

1 reference

Association of metabolic syndrome and benign prostate enlargement in young korean males

21 January 2018

1 reference

Relationship between metabolic syndrome and prostate volume in Korean men under 50 years of age.

21 January 2018

1 reference

Metabolic syndrome associated with reduced lower urinary tract symptoms in middle-aged men receiving health checkup.

21 January 2018

1 reference

The relationship between lower urinary tract symptoms/benign prostatic hyperplasia and the number of components of metabolic syndrome

21 January 2018

1 reference

Prostate volume changes over time: results from the Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation

21 January 2018

1 reference

PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS.

21 January 2018

1 reference

Ezetimibe reduces enlarged prostate in an animal model of benign prostatic hyperplasia

21 January 2018

1 reference

Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans

21 January 2018

1 reference

Serum lipid levels in benign prostatic hyperplasia

21 January 2018

1 reference

History of weight and obesity through life and risk of benign prostatic hyperplasia

21 January 2018

1 reference

Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men.

21 January 2018

1 reference

Impact of treatment with statins on prostate-specific antigen and prostate volume in patients with benign prostatic hyperplasia

21 January 2018

1 reference

Body mass index and risk of BPH: a meta-analysis

21 January 2018

1 reference

A prospective study of obesity, and the incidence and progression of lower urinary tract symptoms

21 January 2018

1 reference

Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms

21 January 2018

1 reference

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

Macronutrients, fatty acids, cholesterol, and risk of benign prostatic hyperplasia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJU.12728

1 reference

2 August 2017

1 reference

PubMed ID

24602293